Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice
about
Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discoveryMatrix Metalloproteinases in Non-Neoplastic Disorders.Perspectives for Monocyte/Macrophage-Based Diagnostics of Chronic InflammationRole of vascular smooth muscle cell in the inflammation of atherosclerosisDiverse functions of matrix metalloproteinases during fibrosisPerspectives on reprograming cancer-associated dendritic cells for anti-tumor therapiesThe Role of Different Monocyte Subsets in the Pathogenesis of Atherosclerosis and Acute Coronary SyndromesMolecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models.The Roles of CD137 Signaling in AtherosclerosisBiochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decadeMatrix Metalloproteinase 9 (MMP-9) Regulates Vein Wall Biomechanics in Murine Thrombus ResolutionAcrolein activates matrix metalloproteinases by increasing reactive oxygen species in macrophagesMacrophages in the pathogenesis of atherosclerosisMolecular mechanisms of collagen isotype-specific modulation of smooth muscle cell phenotypeA dynamic model of calcific nodule destabilization in response to monocyte- and oxidized lipid-induced matrix metalloproteinases.GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression.Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death.MMP-9 sheds the beta2 integrin subunit (CD18) from macrophages.Fine ambient air particulate matter exposure induces molecular alterations associated with vascular disease progression within plaques of atherosclerotic susceptible mice.Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice.Allele-specific regulation of matrix metalloproteinase-3 gene by transcription factor NFkappaBHuman macrophage foam cells degrade atherosclerotic plaques through cathepsin K mediated processesAccumulation of gene polymorphisms related to plaque disruption and thrombosis is associated with cerebral infarction in subjects with type 2 diabetes.Lysophosphatidic Acid Is Associated with Atherosclerotic Plaque Instability by Regulating NF-κB Dependent Matrix Metalloproteinase-9 Expression via LPA2 in Macrophages.Toll-like receptor 7 deficiency protects apolipoprotein E-deficient mice from diet-induced atherosclerosisA macrophage cell model for selective metalloproteinase inhibitor designTargeting pancreatic cancer with magneto-fluorescent theranostic gold nanoshells.Inflammation and the osteogenic regulation of vascular calcification: a review and perspective.Nitro-fatty acids reduce atherosclerosis in apolipoprotein E-deficient mice.ADAMTS-7 is associated with a high-risk plaque phenotype in human atherosclerosis.Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.Overexpression of urokinase by plaque macrophages causes histological features of plaque rupture and increases vascular matrix metalloproteinase activity in aged apolipoprotein e-null miceArterial colony stimulating factor-1 influences atherosclerotic lesions by regulating monocyte migration and apoptosis.Suppressed accumulation of cerebral amyloid {beta} peptides in aged transgenic Alzheimer's disease mice by transplantation with wild-type or prostaglandin E2 receptor subtype 2-null bone marrowA comparison of vascular effects from complex and individual air pollutants indicates a role for monoxide gases and volatile hydrocarbons.Inducible transgenes under the control of the hCD68 promoter identifies mouse macrophages with a distribution that differs from the F4/80 - and CSF-1R-expressing populations.Overexpression of MMP-9 and its inhibitors in blood mononuclear cells after myocardial infarction--is it associated with depressive symptomatology?Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stabilitySize- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages.Human CD68 promoter GFP transgenic mice allow analysis of monocyte to macrophage differentiation in vivo.
P2860
Q21285000-5C3ECDE9-C4A0-40EF-BA3E-272230086832Q26741827-4788AEC0-EBF7-4F2A-B310-EA74435E2975Q26745913-54A188CD-C00F-409C-9038-061FA9BFE4A6Q26823875-C0B9672D-5791-4B6B-BD79-7C9252CF3D9CQ26825368-E9C398F4-3126-4F0C-AF71-9EE731DFAC9AQ26830839-BFD8E281-3F05-4251-9053-8242862B8D5BQ26852646-37BE0B1D-B9D9-4515-97FB-99958D21D4FAQ28070313-AA136C05-D4E0-458D-B201-F160513F813EQ28076613-657B5232-4529-46B7-9812-C724F299285EQ28288148-5C63E34A-B0AF-48B4-87B2-6CCAB5AF8E1DQ28548467-A433284A-DF9E-41BD-945B-1826406EEE92Q28754552-7A4137A0-E548-429E-B35A-AE462C357443Q29617765-0AA7906D-CA17-4C2D-981D-F47DDEB7CD6CQ30439442-15A03FDD-23C8-4AC8-B5F8-B9811C79A43FQ30505733-EE019EE4-CB83-4007-84ED-C3E88D556485Q30540007-33845597-8A28-4DE5-9165-D0EDF1D1B040Q30646015-6ECD3A33-1835-4C3E-83CF-74BE5761E23BQ33396615-9C7FF057-5F15-47FA-A40D-22184ECA2EADQ33460643-C0363E78-BF7F-48FA-BFB7-B8F9B1644A8AQ33547771-EFBFA2B6-A9DC-443D-9FE9-59CD5AAA11A6Q33548692-BC3FA6E7-A99B-4181-80DF-74FCA1595187Q33561251-EB30F957-C64A-441E-AF7B-5F8F7DCC27D6Q33602311-3BE27557-D613-43CC-A806-A3DCC89A1E43Q33607215-51261AEC-3CD0-4A7B-8F18-989397417168Q33678336-FACF6110-6ECE-4ED5-99C7-77751395C8C4Q33680972-1F5D58AE-9509-4BCA-B63E-05918B62F379Q33735020-820F35EC-795A-4497-8215-F8E71BD0770CQ33782750-294BAB97-EA6D-41DA-B89C-FAA965EB41B4Q33803709-9D210B54-8CA2-481E-B9F7-E4F02B0D800DQ33808002-0F6957A8-0A3E-4645-90E3-E94384E240D3Q33839384-E57EB832-3094-4CFD-9ECA-31ABF826CB79Q33858160-90391B8D-16CF-4AC5-A61B-2F3CA105FF6EQ33902070-9F8E8A6D-5310-45FF-81B9-2B5B8F7DB6E4Q33947287-3171C44D-666E-4139-BC82-BE46E5037EE3Q34063069-EAC92387-A081-4E3C-8DA3-8442718DF716Q34078078-059E279C-0182-45F8-8FD2-97FAD012D99DQ34083836-3A9FF3F8-1DA9-483D-B44D-19DA5F88F38EQ34134537-BBD75CCD-7BFF-48A5-B3CF-8615DE5F61F2Q34167795-F8BEAACA-C8E8-45A4-899D-6D7F7A1DD04AQ34318508-AF8DDD5F-DFF3-4446-9FEA-92E52E690474
P2860
Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Macrophage expression of activ ...... ruption in apoE-deficient mice
@ast
Macrophage expression of activ ...... ruption in apoE-deficient mice
@en
Macrophage expression of activ ...... ruption in apoE-deficient mice
@nl
type
label
Macrophage expression of activ ...... ruption in apoE-deficient mice
@ast
Macrophage expression of activ ...... ruption in apoE-deficient mice
@en
Macrophage expression of activ ...... ruption in apoE-deficient mice
@nl
prefLabel
Macrophage expression of activ ...... ruption in apoE-deficient mice
@ast
Macrophage expression of activ ...... ruption in apoE-deficient mice
@en
Macrophage expression of activ ...... ruption in apoE-deficient mice
@nl
P2093
P2860
P356
P1476
Macrophage expression of activ ...... ruption in apoE-deficient mice
@en
P2093
Elaine W Raines
Ivan G Gomez
Paul T Wille
Peter J Gough
P2860
P356
10.1172/JCI25074
P407
P577
2005-12-22T00:00:00Z